David M. Kendall - Concepedia

Author

David M. Kendall

Also Known As

A Hasofer, A. I. Gladkich, D KENDALL, D Kendall, D M Kendall, D. KENDALL, D. Kendall, D. M. Kendall, D.M. Kendall, DAVID KENDALL

163

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota Eli Lilly (United States)University of North Carolina at Chapel Hill Park Nicollet Clinic Diabetes Australia

About

David M. Kendall is an author at University of Minnesota specializing in diabetes, medicine, and islet transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	2.8K
2	Public Health	6	6	616
3	Health Sciences	5	5	328
4	Education	2	2	29
5	Biostatistics	2	2	29

David M. Kendall

Publications

Citations

H-Index

Page 1

	Year	Citations
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Diabetes Care	2005	1.2K
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study Daniel J. Drucker, John B. Buse, Kristin Taylor, The Lancet Non-pharmacological InterventionDiabetes ManagementInsulin ManagementDiabetesType 2	2008	1.1K
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia Ronald Goldberg, David M. Kendall, Mark A. Deeg, Diabetes Care	2005	795
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes Lawrence Blonde, E. Klein, J. Han, Diabetes Obesity and Metabolism	2006	417
Recommendations for Management of Diabetes During Ramadan Monira Alarouj, Samir H. Assaad‐Khalil, John B. Buse, Diabetes Care FastingObesityMetabolic SyndromeDiabetes EpidemiologyPublic Health	2010	402
Assessment of Group Versus Individual Diabetes Education Patti Rickheim, Todd Weaver, Jill. L. Flader, Diabetes Care	2002	399
One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients Mathijs C. Bunck, Michaëla Diamant, A. H. Corner, Diabetes Care	2009	385
Effects of Hemipancreatectomy on Insulin Secretion and Glucose Tolerance in Healthy Humans David M. Kendall, David E.R. Sutherland, John S. Najarian, New England Journal of Medicine	1990	246
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial Anthony Barnett, Jude Burger, Don Johns, Clinical Therapeutics Metabolic SyndromeDiabetes ManagementInsulin ManagementDiabetesPharmacology	2007	240
Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort Zhuo Chen, Miao Feng, Andrew D. Paterson, Proceedings of the National Academy of Sciences	2016	238

Page 1